Clinical Trial Update: LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma [EARLY_Phase 1]

View source ↗

Summary

This is an early-phase pilot study of glucarpidase in patients with primary central nervous system lymphoma. The trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• Glucarpidase (glucarpidase)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Central Nervous System Lymphoma | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING